Which two immunohistochemical markers would indicate a primary lung adenocarcinoma?

Prepare for the CMID Test. Study with flashcards and multiple choice questions, each question contains hints and explanations. Get ready for your exam with confidence!

Multiple Choice

Which two immunohistochemical markers would indicate a primary lung adenocarcinoma?

Explanation:
Immunohistochemical markers help reveal where a tumor started. TTF-1 is a nuclear protein expressed in lung and thyroid epithelium, and in lung cancers it is most commonly positive in adenocarcinoma, signaling a pulmonary origin. Napsin A is a cytoplasmic enzyme present in type II pneumocytes and is positive in most lung adenocarcinomas while being negative in squamous cell carcinomas. When both TTF-1 and Napsin A are positive, it strongly supports a primary lung adenocarcinoma rather than a metastasis from another site or a different histology. Neuroendocrine markers like synaptophysin and chromogranin point toward neuroendocrine tumors, not adenocarcinoma. p63 highlights squamous differentiation, which argues against adenocarcinoma. So the combination of TTF-1 and Napsin A is the most specific for primary lung adenocarcinoma.

Immunohistochemical markers help reveal where a tumor started. TTF-1 is a nuclear protein expressed in lung and thyroid epithelium, and in lung cancers it is most commonly positive in adenocarcinoma, signaling a pulmonary origin. Napsin A is a cytoplasmic enzyme present in type II pneumocytes and is positive in most lung adenocarcinomas while being negative in squamous cell carcinomas. When both TTF-1 and Napsin A are positive, it strongly supports a primary lung adenocarcinoma rather than a metastasis from another site or a different histology.

Neuroendocrine markers like synaptophysin and chromogranin point toward neuroendocrine tumors, not adenocarcinoma. p63 highlights squamous differentiation, which argues against adenocarcinoma. So the combination of TTF-1 and Napsin A is the most specific for primary lung adenocarcinoma.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy